Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
The U.S. Justice Department's bankruptcy watchdog accused Sorrento Therapeutics lawyers of submitting false paperwork for the company's chapter 11 filing in Houston. United Therapeutics has initiated litigation against the FDA, alleging that the agency allowed Liquidia to bypass FDA rules in the drug approval process.
United Therapeutics starts litigation with FDA over rival Liquidia's drug application https://t.co/oe6dm3kegk https://t.co/uakyLhgN9y
United Therapeutics, in unusual step, sues FDA over rival’s drug application https://t.co/8OsrZidJ6i by Kristin Jensen $UTHR $LQDA
United Therapeutics, in unusual step, sues FDA over rival’s drug application https://t.co/zC9bXWH3Ou $UTHR by Kristin Jensen
